We are building an innovative technology-led company focused on providing rapid and near-patient medical diagnostic testing solutions.
We are developing, manufacturing and selling products and systems that support the migration of testing from the laboratory closer to the patient with the intention of improving both clinical and economic healthcare outcomes. Our initial clinical focus is on developing a range of rapid testing products in the areas of hematology oncology, specifically B-cell dyscrasias.
We will use our expertise in immunodiagnostics, plastic electronics, hardware and software, to develop the next generation of testing systems that meet the needs of our customers. Our current platform development is looking to provide customers with a multiplexed, portable, cost-effective and connected rapid testing solution.
© Abingdon Health 2017